Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors
Clinical trial NCT00011414 · COMPLETED
Trial details
- NCT number
- NCT00011414
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-02-15
- Primary completion
- 2007-11-28
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.